Can we cure rheumatoid arthritis?

Area of Science:

• Immunology
• Rheumatology
• Therapeutics Development

Background:

• Rheumatoid arthritis (RA) is a progressive autoimmune disease despite current treatments.
• Sustained drug-free remission (SDFR) or cure for RA is rarely achieved.
• Barriers to cure include immune resilience, stromal activation, structural damage, and genetics.

Purpose of the Study:

• To review advancements in RA therapeutics.
• To evaluate if emerging therapies can lead to immunological normalization and cure.
• To assess the potential of new treatments to shift the paradigm from management to cure.

Main Methods:

• Review of current literature on RA therapeutics.
• Analysis of emerging therapies like novel biologics, cellular interventions, and gene editing.
• Evaluation of preclinical and early clinical data on disease trajectory modification.

Main Results:

• Current treatments improve outcomes but do not offer a cure.
• Emerging therapies aim to reprogram immune responses, offering potential for SDFR and cure.
• Early data suggest potential for disease trajectory modification, but durable immune resetting is not yet proven.

Conclusions:

• Definitive cure for RA is not yet attainable but is a future goal.
• Precision medicine, next-generation immunotherapy, and translational research are driving a shift towards curative strategies.
• The 'window of opportunity' for early intervention remains a key area for research in RA treatment.